TY - JOUR
T1 - The dual functions of the extreme N-terminus of TDP-43 in regulating its biological activity and inclusion formation
AU - Zhang, Yong Jie
AU - Caulfield, Thomas
AU - Xu, Ya Fei
AU - Gendron, Tania F.
AU - Hubbard, Jaime
AU - Stetler, Caroline
AU - Sasaguri, Hiroki
AU - Whitelaw, Ena C.
AU - Cai, Shuyi
AU - Lee, Wing Cheung
AU - Petrucelli, Leonard
N1 - Funding Information:
This work was supported by Mayo Clinic Foundation to L.P., National Institutes of Health/National Institute on Aging (R01AG026251 to L.P.), National Institutes of Health/National Institute of Neurological Disorders and Stroke (R01 NS 063964-01 to L.P., R01 NS077402 to L.P., ES20395-01 to L.P., R21 NS074121-01 to T.F.G., 1R21NS079807-01A1 to Y.Z.), Amyotrophic Lateral Sclerosis Association to L.P., GHR Foundation to Y.Z, and the Department of Defense (W81XWH-10-1-0512-1 to L.P. and W81XWH-09-1-0315AL093108 to L.P.). Funding to pay the Open Access publication charges for this article was provided by Mayo Clinic (Department of Neuroscience).
PY - 2013/8
Y1 - 2013/8
N2 - TAR DNA-binding protein-43 (TDP-43) is the principal component of ubiquitinated inclusions in amyotrophic lateral sclerosis (ALS) and the most common pathological subtype of frontotemporal dementia- frontotemporal lobar degeneration with TDP-43-positive inclusions (FTLD-TDP). To date, the C-terminus of TDP-43, which is aggregation-prone and contains almost all ALS-associated mutations, has garnered much attention while the functions of the N-terminus of TDP-43 remain largely unknown. To bridge this gap in our knowledge, we utilized novel cell culture and computer-assisted models to evaluate which region(s) of TDP- 43 regulate its folding, self-interaction, biological activity and aggregation. We determined that the extreme N-terminus of TDP-43, specifically the first 10 residues, regulates folding of TDP-43 monomers necessary for proper homodimerization and TDP-43-regulated splicing. Despite such beneficial functions, we discovered an interesting dichotomy: full-length TDP-43 aggregation, which is believed to be a pathogenic process, also requires the extreme N-terminus of TDP-43. As such, we provide new insight into the structural basis for TDP-43 function and aggregation, and we suggest that stabilization of TDP-43 homodimers, the physiologically active form of TDP-43, may be a promising therapeutic strategy for ALS and FTLD-TDP.
AB - TAR DNA-binding protein-43 (TDP-43) is the principal component of ubiquitinated inclusions in amyotrophic lateral sclerosis (ALS) and the most common pathological subtype of frontotemporal dementia- frontotemporal lobar degeneration with TDP-43-positive inclusions (FTLD-TDP). To date, the C-terminus of TDP-43, which is aggregation-prone and contains almost all ALS-associated mutations, has garnered much attention while the functions of the N-terminus of TDP-43 remain largely unknown. To bridge this gap in our knowledge, we utilized novel cell culture and computer-assisted models to evaluate which region(s) of TDP- 43 regulate its folding, self-interaction, biological activity and aggregation. We determined that the extreme N-terminus of TDP-43, specifically the first 10 residues, regulates folding of TDP-43 monomers necessary for proper homodimerization and TDP-43-regulated splicing. Despite such beneficial functions, we discovered an interesting dichotomy: full-length TDP-43 aggregation, which is believed to be a pathogenic process, also requires the extreme N-terminus of TDP-43. As such, we provide new insight into the structural basis for TDP-43 function and aggregation, and we suggest that stabilization of TDP-43 homodimers, the physiologically active form of TDP-43, may be a promising therapeutic strategy for ALS and FTLD-TDP.
UR - http://www.scopus.com/inward/record.url?scp=84880323707&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880323707&partnerID=8YFLogxK
U2 - 10.1093/hmg/ddt166
DO - 10.1093/hmg/ddt166
M3 - Article
C2 - 23575225
AN - SCOPUS:84880323707
SN - 0964-6906
VL - 22
SP - 3112
EP - 3122
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 15
ER -